ReviewCancer management and research2024

Combination Atezolizumab, Cobimetinib, and Vemurafenib as a Treatment Option in BRAF V600 Mutation-Positive Melanoma: Patient Selection and Perspectives.

Michelle M Dugan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.